Stay updated on Tucidinostat & Tislelizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Tucidinostat & Tislelizumab in NSCLC Clinical Trial page.

Latest updates to the Tucidinostat & Tislelizumab in NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2 to the study record history. Removed the government funding notice and the older Revision: v3.4.1.SummaryDifference0.9%

- Check21 days agoChange DetectedA site-wide notice about government funding and operating status was added, and the record history shows a version update from v3.4.0 to v3.4.1.SummaryDifference0.9%

- Check28 days agoChange DetectedThe update adds a glossary toggle, introduces green/red highlights for additions and deletions, and a new Revision: v3.4.0 banner; no changes to study data or results are observed.SummaryDifference1%

- Check64 days agoChange DetectedA new entry Revision: v3.3.3 was added to the record history. The HHS Vulnerability Disclosure and the older Revision: v3.3.2 were removed from the footer.SummaryDifference0.2%

- Check92 days agoChange DetectedA minor revision entry (v3.3.2) was added and v3.2.0 was removed from the revision history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check99 days agoChange DetectedThe page no longer shows the government funding/operating status notice. The banner warning about updates and operating status may no longer appear on the record history page.SummaryDifference0.8%

Stay in the know with updates to Tucidinostat & Tislelizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tucidinostat & Tislelizumab in NSCLC Clinical Trial page.